-

City of Hope Researchers Discover Why Taking a Mushroom Supplement Slows or Prevents Prostate Cancer From Getting Worse

The bidirectional research looks at both laboratory and human clinical trial data, finding that medicinal use of white button mushroom reduces the type of cells that weaken the immune system and allow prostate cancer to spread

LOS ANGELES--(BUSINESS WIRE)--Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, ranked among the nation’s top 5 cancer centers by U.S. News & World Report and a national leader in providing cancer patients with best-in-class, integrated supportive care programs, now understand why taking an investigational white button mushroom supplement shows promise in slowing and even preventing prostate cancer from spreading among men who joined a phase 2 clinical trial studying “food as medicine.” Looking at preclinical and preliminary human data, the City of Hope scientists found that taking white button mushroom pills reduces a class of immune cells called myeloid-derived suppressor cells (MDSCs), which has been linked to cancer development and spread.

“City of Hope researchers are investigating foods like white button mushroom, grape seed extract, pomegranate, blueberries and ripe purple berries called Jamun for their potential medicinal properties. We’re finding that plant-derived substances may one day be used to support traditional cancer treatment and prevention practices,” said Shiuan Chen, Ph.D., the Lester M. and Irene C. Finkelstein Chair in Biology, professor and chair of the Department of Cancer Biology and Molecular Medicine at Beckman Research Institute of City of Hope, and senior author of the new Clinical and Translational Medicine study. “This study suggests that ‘food as medicine’ treatments could eventually become normal, evidence-based cancer care that is recommended for everyone touched by cancer.”

The use of naturally derived therapies for cancer treatment — called integrative oncology — is growing in popularity as people become more health conscious and aware of the benefits of whole-person cancer care. Supported by a $100 million gift from Panda Express Co-CEOs Andrew and Peggy Cherng, City of Hope’s Cherng Family Center for Integrative Oncology is accelerating the research, education and clinical care needed to ensure cancer patients and their doctors have access to safe, proven approaches.

At City of Hope, lab researchers work closely with physicians, allowing for streamlined bidirectional research so that laboratory findings can be taken to patients and what is observed in patients can be taken and put back under the microscope for the development of expedited, more effective cancer treatments.

In mouse models, researchers found that administration of white button mushroom extract significantly delayed the growth of tumors and extended the survival of mice. It also improved T cell immune response through the reduction of MDSC levels in animal models, meaning it improved the immune system’s ability to kill cancer.

The researchers profiled blood draws from some of the men participating in City of Hope’s phase 2 clinical trial. The men were under active surveillance as they took white button mushroom supplements. Focusing on eight participants’ samples before and after three months of white button mushroom treatment, the scientists found that there were less tumor-creating MDSCs and more anti-tumor T and natural killer cells, suggesting white button mushroom rebuilds anti-cancer immune defense and slows cancer growth.

“Our study emphasizes the importance of seeking professional guidance to ensure safety and to avoid self-prescribing supplements without consulting a health care provider,” said Xiaoqiang Wang, M.D., Ph.D., City of Hope staff scientist and first author of the study. “Some people are buying mushroom products or extract online, but these are not FDA-approved. While our research has promising early results, the study is ongoing. That said, it couldn’t hurt if people wanted to add more fresh white button mushrooms to their everyday diet.”

People interested in joining the National Cancer Institute-funded phase 2 clinical trial should visit https://www.cityofhope.org/research/clinical-trials. City of Hope researchers are now focusing on whether the reduction in MDSCs is associated with improved clinical outcomes in patients with prostate cancer.

The Clinical and Translational Medicine study “Reduction of myeloid-derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment” was supported by a National Institutes of Health grant for City of Hope Core Facilities (P30CA033572), a National Cancer Institute grant to Dr. Chen (CA227230) and a pilot study grant from the Panda Charitable Foundation.

About City of Hope

City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S., and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.

Contacts

Zen Logsdon
626-409-9367
zlogsdon@coh.org

City of Hope


Release Versions

Contacts

Zen Logsdon
626-409-9367
zlogsdon@coh.org

More News From City of Hope

City of Hope Celebrates Cancer Survivors and Physicians with Stunning Rose Parade Float

LOS ANGELES--(BUSINESS WIRE)--City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, will highlight how advances in cancer research and treatment are bringing hope to cancer patients and survivors everywhere with a remarkable float and six inspiring riders in the 2026 Rose Parade on Jan. 1. The float, titled “Overcoming Can...

Cancer Research and Care in 2026: 5 Big Shifts That Will Redefine Survival and Access

LOS ANGELES--(BUSINESS WIRE)--Cancer is complex, with a future full of both promise and uncertainty. From artificial intelligence transforming data into lifesaving insights to gut microbiome-guided therapies that turn food into medicine, experts at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, share five predictions for how scientific innovation will continue to transform cancer treatment and survivorship in 2026. These bre...

Robert Stone Recognized as a Top Healthcare CEO in 2025

LOS ANGELES--(BUSINESS WIRE)--City of Hope® CEO Robert Stone, who leads one of the largest and most advanced cancer research and treatment organizations in the United States, has been recognized as one of the most influential leaders by two top health care trade publications: Modern Healthcare and Becker’s Hospital Review. Stone was honored for expanding access to advanced cancer care nationwide, advancing breakthrough cancer research, and developing a national network of lifesaving clinical tr...
Back to Newsroom